23 research outputs found
Multiple-clone infections of Plasmodium vivax: definition of a panel of markers for molecular epidemiology
Submitted by Nuzia Santos ([email protected]) on 2016-02-29T17:46:50Z
No. of bitstreams: 1
Multiple-clone infections of Plasmodium.pdf: 5467763 bytes, checksum: b4719a5dd04db8f670d04a87ecc9303f (MD5)Approved for entry into archive by Nuzia Santos ([email protected]) on 2016-02-29T17:50:22Z (GMT) No. of bitstreams: 1
Multiple-clone infections of Plasmodium.pdf: 5467763 bytes, checksum: b4719a5dd04db8f670d04a87ecc9303f (MD5)Made available in DSpace on 2016-02-29T17:50:22Z (GMT). No. of bitstreams: 1
Multiple-clone infections of Plasmodium.pdf: 5467763 bytes, checksum: b4719a5dd04db8f670d04a87ecc9303f (MD5)
Previous issue date: 2015Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, BrasilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, BrasilUniversidade Federal de Mato Grosso. Hospital Julio Muller. Cuiabå, MT, BrasilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, BrasilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, BrasilFundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, BrasilBACKGROUND: Plasmodium vivax infections commonly contain multiple genetically distinct parasite clones. The detection of multiple-clone infections depends on several factors, such as the accuracy of the genotyping method, and the type and number of the molecular markers analysed. Characterizing the multiplicity of infection has broad implications that range from population genetic studies of the parasite to malaria treatment and control. This study compared and evaluated the efficiency of neutral and non-neutral markers that are widely used in studies of molecular epidemiology to detect the multiplicity of P. vivax infection.
METHODS: The performance of six markers was evaluated using 11 mixtures of DNA with well-defined proportions of two different parasite genotypes for each marker. These mixtures were generated by mixing cloned PCR products or patient-derived genomic DNA. In addition, 51 samples of natural infections from the Brazil were genotyped for all markers. The PCR-capillary electrophoresis-based method was used to permit direct comparisons among the markers. The criteria for differentiating minor peaks from artifacts were also evaluated.
RESULTS: The analysis of DNA mixtures showed that the tandem repeat MN21 and the polymorphic blocks 2 (msp1B2) and 10 (msp1B10) of merozoite surface protein-1 allowed for the estimation of the expected ratio of both alleles in the majority of preparations. Nevertheless, msp1B2 was not able to detect the majority of multiple-clone infections in field samples; it identified only 6 % of these infections. The merozoite surface protein-3 alpha and microsatellites (PvMS6 and PvMS7) did not accurately estimate the relative clonal proportions in artificial mixtures, but the microsatellites performed well in detecting natural multiple-clone infections. Notably, the use of a less stringent criterion to score rare alleles significantly increased the sensitivity of the detection of multi-clonal infections.
CONCLUSIONS: Depending on the type of marker used, a considerable amplification bias was observed, which may have serious implications for the characterization of the complexity of a P. vivax infection. Based on the performance of markers in artificial mixtures of DNA and natural infections, a minimum panel of four genetic markers (PvMS6, PvMS7, MN21, and msp1B10) was defined, and these markers are highly informative regarding the genetic variability of P. vivax populations
Human migration and the spread of malaria parasites to the New World
We examined the mitogenomes of a large global collection of human malaria parasites to explore how and when Plasmodium falciparum and P. vivax entered the Americas. We found evidence of a significant contribution of African and South Asian lineages to present-day New World malaria parasites with additional P. vivax lineages appearing to originate from Melanesia that were putatively carried by the Australasian peoples who contributed genes to Native Americans. Importantly, mitochondrial lineages of the P. vivax-like species P. simium are shared by platyrrhine monkeys and humans in the Atlantic Forest ecosystem, but not across the Amazon, which most likely resulted from one or a few recent human-to-monkey transfers. While enslaved Africans were likely the main carriers of P. falciparum mitochondrial lineages into the Americas after the conquest, additional parasites carried by Australasian peoples in pre-Columbian times may have contributed to the extensive diversity of extant local populations of P. vivax
Multiple-clone infections of Plasmodium vivax: definition of a panel of markers for molecular epidemiology
The complete genome sequence of Chromobacterium violaceum reveals remarkable and exploitable bacterial adaptability
Chromobacterium violaceum is one of millions of species of free-living microorganisms that populate the soil and water in the extant areas of tropical biodiversity around the world. Its complete genome sequence reveals (i) extensive alternative pathways for energy generation, (ii) â500 ORFs for transport-related proteins, (iii) complex and extensive systems for stress adaptation and motility, and (iv) wide-spread utilization of quorum sensing for control of inducible systems, all of which underpin the versatility and adaptability of the organism. The genome also contains extensive but incomplete arrays of ORFs coding for proteins associated with mammalian pathogenicity, possibly involved in the occasional but often fatal cases of human C. violaceum infection. There is, in addition, a series of previously unknown but important enzymes and secondary metabolites including paraquat-inducible proteins, drug and heavy-metal-resistance proteins, multiple chitinases, and proteins for the detoxification of xenobiotics that may have biotechnological applications
Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study
Summary
Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally.
Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies
have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of
the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income
countries globally, and identified factors associated with mortality.
Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to
hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis,
exomphalos, anorectal malformation, and Hirschsprungâs disease. Recruitment was of consecutive patients for a
minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical
status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary
intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause,
in-hospital mortality for all conditions combined and each condition individually, stratified by country income status.
We did a complete case analysis.
Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital
diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal
malformation, and 517 with Hirschsprungâs disease) from 264 hospitals (89 in high-income countries, 166 in middleincome
countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male.
Median gestational age at birth was 38 weeks (IQR 36â39) and median bodyweight at presentation was 2·8 kg (2·3â3·3).
Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income
countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups).
Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome
countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries;
pâ€0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients
combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88â4·11],
p<0·0001; middle-income vs high-income countries, 2·11 [1·59â2·79], p<0·0001), sepsis at presentation (1·20
[1·04â1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention
(ASA 4â5 vs ASA 1â2, 1·82 [1·40â2·35], p<0·0001; ASA 3 vs ASA 1â2, 1·58, [1·30â1·92], p<0·0001]), surgical safety
checklist not used (1·39 [1·02â1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed
(ventilation 1·96, [1·41â2·71], p=0·0001; parenteral nutrition 1·35, [1·05â1·74], p=0·018). Administration of
parenteral nutrition (0·61, [0·47â0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65
[0·50â0·86], p=0·0024) or percutaneous central line (0·69 [0·48â1·00], p=0·049) were associated with lower mortality.
Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome,
middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will
be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger
than 5 years by 2030
Analysis of genetic variability of Plasmodium vivax isolates from different Brazilian Amazon areas using tandem repeats
This work was supported by the Fundação de
Amparo Ă Pesquisa de Minas Gerais (Fapemig), the Conselho
Nacional de Pesquisa (CNPq), and PAPES/FIOCRUZ.Fundação Oswaldo Cruz. Centro de Pesquisa Rene
Rachou. Laboratoryo of Malaria. Belo Horizonte, MG, Brazil.Universidade Federal de Minas Gerais. Instituto de CiĂȘncias BiolĂłgicas. Departamento de Biologia Geral. Belo Horizonte, MG, Brazil.Faculdade SEAMA. MacapĂĄ, AP, Brazil.Universidade Federal do
Mato Grosso. Departamento de ClĂnica MĂ©dica. CuiabĂĄ, MT, Brazil.MinistĂ©rio da SaĂșde. Secretaria de VigilĂąncia em SaĂșde. Instituto Evandro Chagas. Ananindeua, PA, Brasil.Fundação Oswaldo Cruz. Centro de Pesquisa Rene
Rachou. Laboratory of Malaria. Belo Horizonte, MG, Brazil.Fundação Oswaldo Cruz. Centro de Pesquisa René
Rachou. Laboratory of Malaria. Belo Horizonte, MG, Brazil.Few genetic markers have been described to analyze populations of Plasmodium vivax . The genetic variability of P. vivax has been analyzed mainly among isolates taken from areas ranging from hyper- to holoendemic areas. These
studies of genetic variability have neglected many areas with different epidemiologic profiles. The purpose of this study
was to analyze the genetic variability of P. vivax isolates from four different Brazilian Amazon areas. We chose to study the
five most polymorphic tandem repeats (TRs) identified so far. All TRs studied were polymorphic in at least one studied
population, with a modal allele at nearly all loci. Expected heterozygosity ranged from 0.462 to 0.666 and did not correlate
with the repeat array length. The genetic distances among the populations varied from 0.027 to 0.241, and did not correlate
with their geographic separation. Tandem repeats identified in P. vivax isolates failed to allow geographic clustering
Improving N-terminal protein annotation of <it>Plasmodium</it> species based on signal peptide prediction of orthologous proteins
Abstract Background Signal peptide is one of the most important motifs involved in protein trafficking and it ultimately influences protein function. Considering the expected functional conservation among orthologs it was hypothesized that divergence in signal peptides within orthologous groups is mainly due to N-terminal protein sequence misannotation. Thus, discrepancies in signal peptide prediction of orthologous proteins were used to identify misannotated proteins in five Plasmodium species. Methods Signal peptide (SignalP) and orthology (OrthoMCL) were combined in an innovative strategy to identify orthologous groups showing discrepancies in signal peptide prediction among their protein members (Mixed groups). In a comparative analysis, multiple alignments for each of these groups and gene models were visually inspected in search of misannotated proteins and, whenever possible, alternative gene models were proposed. Thresholds for signal peptide prediction parameters were also modified to reduce their impact as a possible source of discrepancy among orthologs. Validation of new gene models was based on RT-PCR (few examples) or on experimental evidence already published (ApiLoc). Results The rate of misannotated proteins was significantly higher in Mixed groups than in Positive or Negative groups, corroborating the proposed hypothesis. A total of 478 proteins were reannotated and change of signal peptide prediction from negative to positive was the most common. Reannotations triggered the conversion of almost 50% of all Mixed groups, which were further reduced by optimization of signal peptide prediction parameters. Conclusions The methodological novelty proposed here combining orthology and signal peptide prediction proved to be an effective strategy for the identification of proteins showing wrongly N-terminal annotated sequences, and it might have an important impact in the available data for genome-wide searching of potential vaccine and drug targets and proteins involved in host/parasite interactions, as demonstrated for five Plasmodium species.</p
Improving N-terminal protein annotation of Plasmodium species based on signal peptide prediction of orthologous proteins
BACKGROUND: Signal peptide is one of the most important motifs involved in protein trafficking and it ultimately influences protein function. Considering the expected functional conservation among orthologs it was hypothesized that divergence in signal peptides within orthologous groups is mainly due to N-terminal protein sequence misannotation. Thus, discrepancies in signal peptide prediction of orthologous proteins were used to identify misannotated proteins in five Plasmodium species. METHODS: Signal peptide (SignalP) and orthology (OrthoMCL) were combined in an innovative strategy to identify orthologous groups showing discrepancies in signal peptide prediction among their protein members (Mixed groups). In a comparative analysis, multiple alignments for each of these groups and gene models were visually inspected in search of misannotated proteins and, whenever possible, alternative gene models were proposed. Thresholds for signal peptide prediction parameters were also modified to reduce their impact as a possible source of discrepancy among orthologs. Validation of new gene models was based on RT-PCR (few examples) or on experimental evidence already published (ApiLoc). RESULTS: The rate of misannotated proteins was significantly higher in Mixed groups than in Positive or Negative groups, corroborating the proposed hypothesis. A total of 478 proteins were reannotated and change of signal peptide prediction from negative to positive was the most common. Reannotations triggered the conversion of almost 50% of all Mixed groups, which were further reduced by optimization of signal peptide prediction parameters. CONCLUSIONS: The methodological novelty proposed here combining orthology and signal peptide prediction proved to be an effective strategy for the identification of proteins showing wrongly N-terminal annotated sequences, and it might have an important impact in the available data for genome-wide searching of potential vaccine and drug targets and proteins involved in host/parasite interactions, as demonstrated for five Plasmodium species
Anti-Plasmodium vivax duffy binding protein antibodies measure exposure to malaria in the Brazilian Amazon
This work was supported by the UNICEF/UNDP/
Word Bank/WHO Special Program for Research and Training in
Tropical Diseases (TDR), the Brazilian National Research Council
(CNPq), and Fundação de Amparo à Pesquisa do Estado de Minas
Gerais (FAPEMIG).Fundação Oswaldo Cruz. Centro de Pesquisas RenĂ© Rachou. LaboratĂłrio de MalĂĄria. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. Instituto de CiĂȘncias BiolĂłgicas. Belo Horizonte, MG, Brazil.Universidade Federal de Mato Grosso. Hospital
JĂșlio Muller. CuiabĂĄ, MT, Brazil.Fundação Oswaldo Cruz. Centro de Pesquisas RenĂ© Rachou. LaboratĂłrio de MalĂĄria. Belo Horizonte, MG, Brasil.MinistĂ©rio da SaĂșde. Secretaria de VigilĂąncia em SaĂșde. Instituto Evandro Chagas. BelĂ©m, PA, Brasil.Fundação Oswaldo Cruz. Centro de Pesquisas RenĂ© Rachou. LaboratĂłrio de MalĂĄria. Belo Horizonte, MG, Brasil.University of Notre Dame. Department of Biological Sciences. Notre Dame, IN.Fundação Oswaldo Cruz. Centro de Pesquisas RenĂ© Rachou. LaboratĂłrio de MalĂĄria. Belo Horizonte, MG, Brasil.Universidade Federal de Minas Gerais. Instituto de CiĂȘncias BiolĂłgicas. Belo Horizonte, MG, Brazil.Plasmodium vivax Duffy binding protein (DBP) is functionally important in the erythrocyte invasion
process and provides a logical target for vaccine-mediated immunity. In the current study, we demonstrated that DBP
is naturally immunogenic in different populations of the Brazilian Amazon, and the proportions of DBP IgG positive
subjects increased with exposure to malaria, reaching a peak in those subjects with long-term exposure (> 15 years) in
the Amazon area. This profile of antibody response was significantly different from the one observed for the P. vivax
merozoite surface protein 1 (MSP119), which was relatively uniform in areas with markedly different levels of malaria
transmission. In a small sample of adults with symptomless P. vivax infection, we could not detect any significant
correlation between antibodies against these P. vivax proteins and asymptomatic infection. Our study provided an
additional insight by demonstrating cumulative exposure as a determinant that acts independently of host age in
generation of anti-DBP IgG response